RARA CRAFT DATABASE for FDA Medical Devices
510(k)K243872

FDA DEVICE FACTS

BD Veritor System for SARS-CoV-2

Becton, Dickinson and Company

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 16, 2025PRODUCT CODEQVF

Indications for use

The BD Veritor System for SARS‑CoV‑2 is a chromatographic digital immunoassay for the rapid, qualitative detection of SARS‑CoV‑2 nucleocapsid protein antigens directly in anterior nasal swab specimens from individuals with signs and symptoms of upper respiratory infection (i.e., symptomatic). The test is intended for use as an aid in the diagnosis of SARS‑CoV‑2 infections (COVID‑19) in symptomatic individuals when either: tested at least twice over three days with at least 48 hours between tests; or when tested once, and negative by the BD Veritor System for SARS‑CoV‑2 and followed up with a molecular test. A negative test result is presumptive and does not preclude SARS‑CoV‑2 infection; it is recommended these results be confirmed by a molecular SARS‑CoV‑2 assay. Positive results do not rule out co‑infection with other bacteria or viruses and should not be used as the sole basis for diagnosis, treatment, or other patient management decisions. Performance characteristics for SARS‑CoV‑2 were established between April 2024 and August 2024 when SARS‑CoV‑2 Omicron was the predominant SARS‑CoV‑2 variant in circulation. Performance characteristics may vary with newly emerging SARS‑CoV‑2 virus variants.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026